A Hungarian medical researcher has just won the prestigious Körber Prize for his groundbreaking study that could cure blindness.
Botond Roska landed a €1 million ($1.18 million) check from Germany’s Körber Foundation for a gene-based treatment to restore sight, and it’s already entered clinical trials.
Roska, who works in Basel, Switzerland, has discovered a gene-based therapy that reprograms cells in the human eye to perform the work of the light-sensitive receptors necessary for human vision, according to the Körber Foundation. The therapy is meant to reactivate retinas, effectively curing blindness.
According to the Budapest-born scientist, the process that they’ve developed thus far will enable a level of vision similar to watching black-and-white television. Clinical tests on blind volunteers are already underway.
“Roska’s research has woken up hope that new treatment methods might restore the ability to see in the blind,” said Hamburg Mayor Peter Tschentscher at a ceremony honoring the prize recipient.
The Körber Foundation prize, first awarded in 1985, recognizes European-based research projects that apply cutting-edge techniques to the physical sciences.
The son of a computer scientist and a pianist, Roska began his career in medicine “after a detour,” said Tschentscher.
The scientist first studied the cello at the Liszt Ferenc Academy of Music in Budapest, but was forced to give up the instrument following an injury. He then began pursuing medicine and mathematics.
Source: Tanks Good News